These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Greiner MA, Li JY, Mannis MJ. Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948 [Abstract] [Full Text] [Related]
3. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Aldave AJ, Kamal KM, Vo RC, Yu F. Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830 [Abstract] [Full Text] [Related]
6. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Palioura S, Kim B, Dohlman CH, Chodosh J. Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625 [Abstract] [Full Text] [Related]
7. The Boston keratoprosthesis in Stevens-Johnson syndrome. Sayegh RR, Ang LP, Foster CS, Dohlman CH. Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122 [Abstract] [Full Text] [Related]
8. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Zerbe BL, Belin MW, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group. Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678 [Abstract] [Full Text] [Related]
9. International results with the Boston type I keratoprosthesis. Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, Kharashi SA, Jindan MA, Tandon R, Mascarenhas J, Malyugin B, Padilla MD, Maskati Q, Agarwala N, Hutauruk J, Sharma M, Yu F. Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986 [Abstract] [Full Text] [Related]
10. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Li JY, Greiner MA, Brandt JD, Lim MC, Mannis MJ. Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070 [Abstract] [Full Text] [Related]
11. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. Kang JJ, de la Cruz J, Cortina MS. Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042 [Abstract] [Full Text] [Related]
13. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication. Iyer G, Srinivasan B, Gupta J, Rishi P, Sen PR, Bhende P, Gopal L, Padmanabhan P. Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878 [Abstract] [Full Text] [Related]
14. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China. Huang Y, Dong Y, Wang L, Du G, Yu J, Song J, Chiang HH. Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379 [Abstract] [Full Text] [Related]
18. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cade F, Grosskreutz CL, Tauber A, Dohlman CH. Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817 [Abstract] [Full Text] [Related]
19. Visual and clinical outcomes of explantation versus preservation of the intraocular lens during keratoprosthesis implantation. Utine CA, Tzu J, Dunlap K, Akpek EK. J Cataract Refract Surg; 2011 Sep; 37(9):1615-22. PubMed ID: 21855761 [Abstract] [Full Text] [Related]
20. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting. Fadlallah A, Atallah M, Cherfan G, Awwad ST, Syed ZA, Melki SA. Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]